• Metagenomi is a genomic medicines company pioneering precision gene editing systems to advance curative therapies for oncology and genetic diseases • Proprietary and wholly owned gene editing platform offers the potential to expand the range of treatable diseases and to improve patient
President Trump on Wednesday ripped a pre-election poll in the key battleground state of Wisconsin, which showed him trailing Joe Biden by a whopping 17 points, slamming it as “illegal suppression.” — FOX News
A manhunt continued Wednesday for the second suspect who remained at large just two days after Houston Police Sgt. Sean Rios was fatally gunned down after entering a hotel parking lot on his way to work, leaving behind four children. — FOX
Four pro-democracy figures were ousted from the legislature, prompting 15 others to vow to resign in solidarity, as Beijing cracks down on one of the city’s few remaining venues for political opposition. — NYT: Top Stories
Staten Island has bristled at coronavirus restrictions, but now has the highest positive test rate in the New York City. — NYT: Top Stories
Results for our CD19-targeted CAR T cell therapy lisocabtagene maraleucel (liso-cel) in patients with heavily pretreated mantle cell lymphoma and relapsed/refractory chronic lymphocytic leukemia Data showcasing BCMA-targeted CAR T cell therapy idecabtagene vicleucel (ide-cel), including updated results from the Phase 1 CRB-401
The U.S. 150-day delinquency rate reached its highest level since at least January 1999 Forbearance provisions have helped foreclosure rates maintain historic lows IRVINE, Calif.–(BUSINESS WIRE)–#Foreclosure–CoreLogic® (NYSE: CLGX), a leading global property information, analytics and data-enabled solutions provider, today released its monthly
The arrival of Theta broke the annual record for the number of storms strong enough to be given names. That benchmark was set in 2005 — the year Hurricane Katrina hit the Gulf Coast. — NYT: Top Stories
It won’t be easy, but coming after a self-styled “disrupter” opens up its own possibilities. — NYT: Top Stories